Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics Firm Xagenic today announced that it has raised C$15 million ($11.8 million) in new financing that it hopes will accelerate its efforts to develop and commercialize its point-of-care diagnostic platform.

Headquartered in Toronto, Xagenic has been developing a platform it calls the Xagenic X1 based on a core technology that was originally developed by researchers at the University of Toronto.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.